VEDS Scientific Meeting Day 2022

Contact Veristat Now

Request A Proposal

Contact Us

Join Veristat and ACER Therapeutics at the VEDS Scientific Meeting Day  2022


ACER Therapeutics


ACER Therapeutics Decentralized Study Design: A Phase 3 Clinical Study in Patients with COL3A1-Positive Vascular Ehlers-Danlos Syndrome to Determine Whether Celiprolol Delays the Onset of vEDS-related Clinical Events abstract has been accepted to the poster session.


The one-day in-person meeting will be held on Monday, August 29, 2022, from 8:00am – 5:00 pm in Paris, France, as part of The Marfan Foundation’s Science in Paris meeting. Follow the conference link (below) to learn more.



VEDS_Conference science-in-paris2022


Conference Details